PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-23
DOI
10.3389/fgene.2020.01020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Taking One Step Back in Familial Hypercholesterolemia
- (2020) Natalia Loaiza et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- In Silico Insights into Protein–Protein Interaction Disruptive Mutations in the PCSK9-LDLR Complex
- (2020) William R. Martin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
- (2019) Alba Carreras et al. BMC BIOLOGY
- Novel strategies to target PCSK9: beyond monoclonal antibodies
- (2019) Nabil G Seidah et al. CARDIOVASCULAR RESEARCH
- Identification of amino acid residues in the ligand binding repeats of LDLR important for PCSK9 binding
- (2019) Shi-jun Deng et al. JOURNAL OF LIPID RESEARCH
- Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems
- (2019) Peipei Chen et al. Frontiers in Physiology
- Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
- (2019) Henry N. Ginsberg et al. CARDIOVASCULAR DRUGS AND THERAPY
- Triple-Targeting Delivery of CRISPR/Cas9 to Reduce the Risk of Cardiovascular Diseases
- (2019) Lingmin Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)
- (2019) Ali Ben Djoudi Ouadda et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9
- (2019) Rosa M. Sánchez-Hernández et al. ATHEROSCLEROSIS
- Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
- (2019) Charles A. German et al. BIODRUGS
- Diagnostic gene sequencing panels: from design to report—a technical standard of the American College of Medical Genetics and Genomics (ACMG)
- (2019) Lora J. H. Bean et al. GENETICS IN MEDICINE
- Inclisiran—New hope in the management of lipid disorders?
- (2019) Krzysztof Dyrbuś et al. Journal of Clinical Lipidology
- Evaluation of the role of STAP1 in Familial Hypercholesterolemia
- (2019) Magdalena Danyel et al. Scientific Reports
- Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia
- (2019) Itziar Lamiquiz-Moneo et al. ATHEROSCLEROSIS
- EGF-A peptides: A promising strategy for PCSK9 inhibition
- (2019) Bertrand Cariou et al. ATHEROSCLEROSIS
- Somatic Editing ofLdlrWith Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research
- (2018) Kelsey E. Jarrett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study
- (2018) Sharon Li Ting Pek et al. ATHEROSCLEROSIS
- PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
- (2018) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy
- (2018) O. Marmontel et al. CLINICAL GENETICS
- Proprotein convertase subtilisin/kexin type 9
- (2018) Robert M. Stoekenbroek et al. CURRENT OPINION IN CARDIOLOGY
- Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells
- (2018) Xi Yang et al. EXPERIMENTAL CELL RESEARCH
- PCSK9 inhibition in the management of familial hypercholesterolemia
- (2018) Masatsune Ogura Journal of Cardiology
- R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction
- (2018) Jose M. Mostaza et al. Journal of Clinical Lipidology
- New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia
- (2018) Sandy Elbitar et al. Scientific Reports
- PCSK9 R496W (rs374603772) and D374Y (rs137852912) mutations in Turkish patients with primary dyslipidemia
- (2018) Zuhal Eroglu Anatolian Journal of Cardiology
- Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan
- (2018) Yun-Chieh Hsiung et al. ATHEROSCLEROSIS
- Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review
- (2018) Urh Groselj et al. ATHEROSCLEROSIS
- Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families
- (2018) Thanh Huong Truong et al. ATHEROSCLEROSIS
- Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project
- (2018) Daiana Ibarretxe et al. ATHEROSCLEROSIS
- A rare STAP1 mutation incompletely associated with familial hypercholesterolemia
- (2018) Francisco Blanco-Vaca et al. CLINICA CHIMICA ACTA
- New Horizons in the Pathogenesis, Pathophysiology and Treatment of Familial Hypercholesterolaemia
- (2018) Margus Viigimaa et al. CURRENT PHARMACEUTICAL DESIGN
- ClinVar database of global familial hypercholesterolemia-associated DNA variants
- (2018) Michael A. Iacocca et al. HUMAN MUTATION
- The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study
- (2018) Ilse K. Luirink et al. Journal of Clinical Lipidology
- Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing
- (2017) Joshua W. Knowles et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry
- (2017) Kuan-Rau Chiou et al. Journal of Clinical Lipidology
- A case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease
- (2017) Mathilde Di Filippo et al. Journal of Clinical Lipidology
- Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials
- (2017) Seyyed Majid Eslami et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys
- (2017) Beth Ann Murphy et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
- (2017) Jiao Li et al. Molecular Medicine Reports
- Nine paths to PCSK9 inhibition
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia
- (2017) Esra Kaya Anatolian Journal of Cardiology
- Familial hypercholesterolaemia
- (2017) Joep C. Defesche et al. Nature Reviews Disease Primers
- PCSK9 signaling pathways and their potential importance in clinical practice
- (2017) Michał Wiciński et al. EPMA Journal
- Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels
- (2017) Chan Joo Lee et al. PLoS One
- Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
- (2017) Maria Donata Di Taranto et al. Scientific Reports
- Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis
- (2016) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- CRISPR-Cas9 Targeting ofPCSK9in Human Hepatocytes In Vivo—Brief ReportSignificance
- (2016) Xiao Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?
- (2016) Yajnavalka Banerjee et al. ATHEROSCLEROSIS
- Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations
- (2016) Rosalind Martin et al. ATHEROSCLEROSIS
- Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia
- (2016) Antoine Rimbert et al. ATHEROSCLEROSIS
- Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
- (2016) Sarah S. Kalia et al. GENETICS IN MEDICINE
- PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis
- (2016) Anne Langsted et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia
- (2016) Naotaka Ohta et al. Journal of Clinical Lipidology
- Point mutations at the catalytic site of PCSK9 inhibit folding, autoprocessing, and interaction with the LDL receptor
- (2016) Colin W. Garvie et al. PROTEIN SCIENCE
- Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays
- (2016) Anne Reiman et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Cascade screening of familial hypercholesterolemia must go on
- (2015) J.M.H. Galema-Boers et al. ATHEROSCLEROSIS
- Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience
- (2015) Damon A. Bell et al. ATHEROSCLEROSIS
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening
- (2015) Siddharth Singh et al. Current Atherosclerosis Reports
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Guidelines for diagnostic next-generation sequencing
- (2015) Gert Matthijs et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153–421): Design, synthesis and biochemical evaluation
- (2015) Rasha H. Alghamdi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Characterisation of de novo mutations in the C-terminal domain of proprotein convertase subtilisin/kexin type 9
- (2015) S. Geschwindner et al. PROTEIN ENGINEERING DESIGN & SELECTION
- PCSK9 R46L, Lower LDL, and Cardiovascular Disease Risk in Familial Hypercholesterolemia
- (2014) Yascara Grisel Luna Saavedra et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) gain-of-function mutation
- (2014) Hiroshi Mabuchi et al. ATHEROSCLEROSIS
- Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study
- (2014) Penny J Norsworthy et al. BMC Medical Genetics
- Design and Synthesis of Truncated EGF-A Peptides that Restore LDL-R Recycling in the Presence of PCSK9 In Vitro
- (2014) Christina I. Schroeder et al. CHEMISTRY & BIOLOGY
- Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
- (2014) Qiurong Ding et al. CIRCULATION RESEARCH
- Mutations in STAP1 Are Associated With Autosomal Dominant Hypercholesterolemia
- (2014) Sigrid W. Fouchier et al. CIRCULATION RESEARCH
- Peeking Into a Cool Future
- (2014) Sergio Fazio et al. CIRCULATION RESEARCH
- Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry
- (2013) Emily C. O’Brien et al. AMERICAN HEART JOURNAL
- The genetic spectrum of familial hypercholesterolemia in Pakistan
- (2013) Waqas Ahmed et al. CLINICA CHIMICA ACTA
- Diagnosis and treatment of familial hypercholesterolaemia
- (2013) G. Kees Hovingh et al. EUROPEAN HEART JOURNAL
- ACMG clinical laboratory standards for next-generation sequencing
- (2013) Heidi L. Rehm et al. GENETICS IN MEDICINE
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mutation detection in Croatian patients with Familial Hypercholesterolemia
- (2012) Ivan Pećin et al. ANNALS OF HUMAN GENETICS
- Common and Low-Frequency Genetic Variants in the PCSK9 Locus Influence Circulating PCSK9 Levels
- (2012) Ekaterina Chernogubova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients
- (2012) Afef Slimani et al. ATHEROSCLEROSIS
- Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia
- (2012) Marianne Abifadel et al. ATHEROSCLEROSIS
- The novel function of HINFP as a co-activator in sterol-regulated transcription ofPCSK9in HepG2 cells
- (2012) Hai Li et al. BIOCHEMICAL JOURNAL
- An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia
- (2011) Lucie Dušková et al. ATHEROSCLEROSIS
- Role of ubiquitination in PCSK9-mediated low-density lipoprotein receptor degradation
- (2011) Yanqun Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture
- (2011) J. Mayne et al. CLINICAL CHEMISTRY
- PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
- (2011) Chun-Yan Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A presumptive new locus for autosomal dominant hypercholesterolemia mapping to 8q24.22
- (2010) A Cenarro et al. CLINICAL GENETICS
- A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1
- (2010) Alice Marques-Pinheiro et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population
- (2010) Ilaria Guella et al. JOURNAL OF LIPID RESEARCH
- PCSK9 Dominant Negative Mutant Results in Increased LDL Catabolic Rate and Familial Hypobetalipoproteinemia
- (2009) Bertrand Cariou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation
- (2009) Tohru Noguchi et al. ATHEROSCLEROSIS
- Multiplex MassARRAY spectrometry (iPLEX) produces a fast and economical test for 56 familial hypercholesterolaemia-causing mutations
- (2009) WT Wright et al. CLINICAL GENETICS
- Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease
- (2009) Marianne Abifadel et al. HUMAN MUTATION
- Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients
- (2009) R A Whittall et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Mutation S462P in the PCSK9 gene reduces secretion of mutant PCSK9 without affecting the autocatalytic cleavage
- (2008) Jamie Cameron et al. ATHEROSCLEROSIS
- A New PCSK9 Gene Promoter Variant Affects Gene Expression and Causes Autosomal Dominant Hypercholesterolemia
- (2008) Sebastian Blesa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Characterization of novel mutations in the catalytic domain of the PCSK9 gene
- (2008) J. Cameron et al. JOURNAL OF INTERNAL MEDICINE
- Molecular population genetics of PCSK9: a signature of recent positive selection
- (2008) Keyue Ding et al. Pharmacogenetics and Genomics
- Molecular basis for LDL receptor recognition by PCSK9
- (2008) H. J. Kwon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutations
- (2008) Khemanganee E Liyanage et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Familial hypercholesterolaemia in Portugal
- (2007) M. Bourbon et al. ATHEROSCLEROSIS
- Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa
- (2007) Vivienne M. Homer et al. ATHEROSCLEROSIS
- Genetic variants in PCSK9 in the Japanese population: Rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population
- (2007) Yasuko Miyake et al. ATHEROSCLEROSIS
- A Novel Splicing Variant of Proprotein Convertase Subtilisin/Kexin Type 9
- (2007) Robert J. Schmidt et al. DNA AND CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started